Results of the bone healing performance of Osteo-Calcium 5 preparation tested by internal fixation surgery patients
- VernacularTitle:Дотуур бэхэлгээ хийх хагалгаанд орсон үйлчлүүлэгчдэд Остео кальци-5 бэлдмэлийн ясны бороололтыг түргэсгэх үйлдлийг судалсан үр дүн
- Author:
Vaanchigsuren S
1
;
Ulziibaatar U
;
Enkhbaatar S
;
Enebish S
;
Seesregdorj S
Author Information
1. Mongolian National University of Medical Sciences (MNUMS) - School of Nursing (SN)
- Publication Type:Journal Article
- Keywords:
Alkaline phosphatase;
Bone fracture;
Osteocalci-5;
TGF-b1
- From:Mongolian Medical Sciences
2015;173(3):32-35
- CountryMongolia
- Language:Mongolian
-
Abstract:
INTRODUCTION: Nowadays, the population of noncommunicable sickness is growing rapidly changing lifestyle is one example of this is the widening of accidents-related bone fractures.The National Center for Trauma Treatment of inpatient hospital from a total fractures 10260 or 30.8%, of which 6777 or 66.05% of the marrow bone fractures as well as drugs used in refractive rarely occupied. PURPOSE: To consider a result of the use of Osteocalcium 5 medical preparation for patients who were diagnosed diaphyseal fracture of the tibia and treated by Intramedullar Osteosyntesis (internal fixation)OBJECTIVES:1. To establish process of fractured bone remodeling to original bone contour by TGF-b1 cytokine dynamics in serum2. To establish process of fractured bone remodeling to original bone contour by alkaline phosphatase dynamics in serumMATERIALS AND METHODS: Within the framework of the survey 28 patients of the “Bone, joint and limb section” Section of the National Institute of Traumatology, aged between 25-60 years, were involved in the present survey. Survey participants were classified in 2 groups according to “Krischner wire” position and their Xray’s images. An accordance to the methodology of James Balch and Mark Stengller (2011) daily dosage of the Osteocalcium 5 preparation for test and comparing patients was determined as following introduced: for test group-twice a day before meal 1.5 grams, for comparing group–Calcium D3Nycomed preparation three times a day during 60 days. Transforming growth factor-beta 1(TGFb1) and Alkaline phosphatase was equal of 3, 14, 42 fraction days.RESULT: The present diagram shows that according to the curve TGF-b1 the bone excrescence performance of the Osteocalcium 5 preparation (0.0001) is statically increasing at 14 days and after 42 days it is statically decreasing and the calculated discrepancy (p<0.015) reveals and proofs the impact of its bone excrescence. Alkaline phosphatase in serum 14 days after the fracture Osteocalcium 5 pills used in chapter Nycomed Calcium D3 drank chapters (116,06±35U/L) compared to a statistical difference (p<0.044).CONCLUSION: Preparations Ostyeokalitsi 5 osteoblast chondrocyte cell activity and enable them synthesized by the cells in the TGF-B1 osteoblast line Alkaline phosphatase synthesized in increased serum concentrations of the bone heal affect signaling molecules involved are determined that quickens recovery.
